Research programme: artemisinin derived compounds - Artemisia BioMedical

Drug Profile

Research programme: artemisinin derived compounds - Artemisia BioMedical

Alternative Names: ART Dimer; ART Dimer-Iron Chelator; ART Dimer-Peptide

Latest Information Update: 13 Jul 2016

Price : $50

At a glance

  • Originator Artemisia BioMedical
  • Class Antimalarials; Antineoplastics; Artemisinins
  • Mechanism of Action Carrier protein inhibitors; Immunomodulators; Mitochondrial protein inhibitors; Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Cancer; Inflammation; Malaria

Highest Development Phases

  • Discontinued Cancer; Inflammation; Malaria

Most Recent Events

  • 13 Jul 2016 Discontinued - Preclinical for Cancer in USA (unspecified route)
  • 13 Jul 2016 Discontinued - Preclinical for Malaria in USA (unspecified route)
  • 13 Jul 2016 Discontinued for Inflammation in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top